Shree Pacetronix Hits 52-Week Low, Receives Strong Sell Rating from MarketsMOJO

Oct 21 2024 10:05 AM IST
share
Share Via
Shree Pacetronix, a microcap company in the medical equipment industry, has hit a 52-week low on October 21, 2024. MarketsMojo has given it a Strong Sell call. The stock has underperformed the sector by -12.21% and is currently trading below its moving averages. The company has not released any statement, and investors are monitoring the situation.


Shree Pacetronix, a microcap company in the medical equipment industry, has recently hit a 52-week low on October 21, 2024. This has led to a "Strong Sell" call by MarketsMOJO, a leading financial analysis platform.

The stock opened today with a loss of -3.13% and has underperformed the sector by -12.21%. It touched an intraday low of Rs. 135, which is a significant decrease of -14.53%. The stock has also shown high volatility today, with an intraday volatility of 6.25%, calculated from the weighted average price.

Shree Pacetronix is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its stock price. This is in contrast to the performance of the Sensex, which has shown a positive growth of 24.14% in the past year, while Shree Pacetronix has seen a decline of -64.02%.

While the company has not released any official statement regarding the recent drop in its stock price, investors and analysts are closely monitoring the situation. Shree Pacetronix has been facing challenges in the highly competitive medical equipment industry, and this dip in its stock price may be a reflection of those challenges.

It is important to note that this article is based on factual information and does not include any external data or sources. It is intended to provide a neutral and informative overview of the current situation of Shree Pacetronix and should not be considered as a recommendation for or against investing in the company. Investors are advised to conduct their own research and make informed decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News